Tag Archives: innovative

Guest Blogspot: Pharmaceutical R & D – the value of radical innovation versus incremental progress

What we really want is affordable products that benefit patients, whether or not they are “innovative” in the usual sense of the word. Scientific innovation is not a medical end in itself. The ultimate aim of pharmaceutical R&D is to … Continue reading

Posted in Business, competition, Department of Health, Drugs, Emerging technologies, Finance, Healthcare, Innovation, NHS, Patients, Pharma, Policy, Research, Technology, Uncategorized | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Guest Blogspot- Dept. of Health Consultation on Drug Pricing: “A new value-based approach to the pricing of branded medicines”

The Department of Health deadline for public submissions on pharmaceutical pricing is this Thursday. Many pitfalls must be avoided if the Government’s proposals are to form the basis of a successful drug pricing policy. Some problems are not easy to … Continue reading

Posted in Andrew Lansley, Business, competition, Department of Health, Drugs, NHS, Pharma, Policy, Research, Uncategorized | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , | 3 Comments

Guest BlogSpot – Which Drugs are the Most Innovative?

Andrew Lansley has recently said: “I am determined that not only will we have a reimbursement price for medicines which reflects their benefit to patients, but also one which incentivises for innovation, and supports those new medicines which respond to … Continue reading

Posted in Andrew Lansley, Department of Health, Drugs, Emerging technologies, NHS, Policy, Research, Technology, Uncategorized | Tagged , , , , , , , , , , , , , , , , , | Leave a comment